July 18, 2017
By Alex Keown, BioSpace.com Breaking News Staff
DURHAM, N.C. – Alcami Corporation, a contract development and manufacturing organization, is moving its leadership team from the shores of North Carolina to the booming biotech haven in the Research Triangle Park area.
It is the strength of RTP that drew Alcami to the area in the first place. The company already maintains a facility in Durham that employs about 50 people. Now the company will move its global headquarters to the area as well, leaving Wilmington. Stephan Kutzer, president and chief executive officer of Alcami, said the move positions the company in a region “known for its culture of diverse expertise, cutting-edge innovation and invention.” RTP is surrounded by top companies, as well as innovative academic programs at area universities including the University of North Carolina at Chapel Hill, Duke University and N.C. State University.
“Our stronger presence in the Triangle is necessary to meet the evolving needs of our clients, accommodate growth, recruit top talent, and attract investors and new customers,” Kutzer said in a statement.
When Alcami completes its transition to its new global headquarters, the company said it intends on adding “critical new jobs.” Those jobs will support the company’s expansion into biologics and provide support for the new global headquarters. Hiring is expected to begin in 2018 and positions will be posted on its online hiring portal, the company said. The company did not specify how many jobs will be available.
Until the transition of the headquarters is complete, executives will maintain offices in both Durham and Wilmington, the company said.
While Alcami is moving its leadership team to Durham, the company made a point to say it is not abandoning its home in Wilmington. The company has approximately 450 employees in the Wilmington area and has strong ties to UNC Wilmington. Last year, the company invested approximately $6 million in the expansion of its manufacturing facilities in Wilmington. The investment in Wilmington included the installation of semi-automated vacuum stopper equipment to “generate prefilled syringe samples that can be used to screen & select components, complete compatibility studies, and conduct developmental stability studies.”
“North Carolina is home to Alcami, and our expansion in the Research Triangle Park area is an investment in the future of the company,” Kutzer said in a statement.
Durham isn’t the only place seeing an Alcami hiring spurt. In May, the company announced it was investing about $5 million into the expansion of its facility in Charleston, S.C. and adding approximately 30 jobs. The Charleston investment will expand the site’s filling and freeze-drying capabilities.
Alcami employees more than 1,000 people. In addition to its sites in North and South Carolina, Alcami maintains several facilities across the United States and also in the Netherlands.
